The Supreme Court agreed Monday to consider a patent infringement case involving a test that helps predict strokes, heart attacks and dementia. Laboratory Corp. was accused of infringing on the patent for the test, which detects deficiencies in vitamin B12 or folic acid. At issue in the company's appeal is whether the patent is invalid because it's not possible to "patent laws of nature, natural phenomena, and abstract ideas."
November 01, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
The Supreme Court agreed Monday to consider a patent infringement case involving a test that helps predict strokes, heart attacks and dementia.
A Burlington, N.C.-based company, Laboratory Corp, was accused of infringing on the patent for the test, which detects deficiencies in vitamin B12 or folic acid.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
